M N Duma1, T Schuster, N Aswathanarayana, L-S Fromm, M Molls, H Geinitz, S Kampfer. 1. Department of Radiation Oncology, Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie, Technische Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675, Munich, Germany, Marciana.Duma@lrz.tum.de.
Abstract
PURPOSE: The goal of the present work was to localize and quantify the actual delivered dose to the cervical spinal cord (SC) during head and neck cancer (H&N) treatment. MATERIALS AND METHODS: A total of 20 H&N patients treated with bilateral nodal irradiation with helical tomotherapy (HT) were analyzed. Daily MVCTs were performed for image guidance. On every second MVCT, the SC was recontoured and the delivered dose for the given treatment fraction (12 fractions per patient) was recalculated. The magnitude and localization (CT slice, spinal cord quadrant) of the Dmax to the SC on the planning CT (PLAN-Dmax) and of the actual delivered Dmax (a-Dmax) were analyzed. RESULTS: A systematic deviation from the PLAN-Dmax was observed in 15 out of 20 patients. Large interpatient variability of the a-Dmax in the spinal cord was noted (4.5±4%). Intrapatient variability in a-Dmax was, generally, minimal (1.8±2.7%). Throughout the treatment course, the higher dose was located in the same CT slices and in the same quadrants (anterior right and anterior left) for the same patient. CONCLUSION: Exact localization and quantification of the change of the a-Dmax can be made for most patients by recalculating the dose on the daily IGRT-MVCTs. This could be helpful in assessing whether replanning is necessary in patients with doses close to the known tolerance doses of the spinal cord.
PURPOSE: The goal of the present work was to localize and quantify the actual delivered dose to the cervical spinal cord (SC) during head and neck cancer (H&N) treatment. MATERIALS AND METHODS: A total of 20 H&N patients treated with bilateral nodal irradiation with helical tomotherapy (HT) were analyzed. Daily MVCTs were performed for image guidance. On every second MVCT, the SC was recontoured and the delivered dose for the given treatment fraction (12 fractions per patient) was recalculated. The magnitude and localization (CT slice, spinal cord quadrant) of the Dmax to the SC on the planning CT (PLAN-Dmax) and of the actual delivered Dmax (a-Dmax) were analyzed. RESULTS: A systematic deviation from the PLAN-Dmax was observed in 15 out of 20 patients. Large interpatient variability of the a-Dmax in the spinal cord was noted (4.5±4%). Intrapatient variability in a-Dmax was, generally, minimal (1.8±2.7%). Throughout the treatment course, the higher dose was located in the same CT slices and in the same quadrants (anterior right and anterior left) for the same patient. CONCLUSION: Exact localization and quantification of the change of the a-Dmax can be made for most patients by recalculating the dose on the daily IGRT-MVCTs. This could be helpful in assessing whether replanning is necessary in patients with doses close to the known tolerance doses of the spinal cord.
Authors: P van Luijk; H P Bijl; R P Coppes; A J van der Kogel; A W Konings; J A Pikkemaat; J M Schippers Journal: Phys Med Biol Date: 2001-11 Impact factor: 3.609
Authors: Daniel Pak; Karen Vineberg; Felix Feng; Randall K Ten Haken; Avraham Eisbruch Journal: Int J Radiat Oncol Biol Phys Date: 2012-01-26 Impact factor: 7.038
Authors: James S Welsh; Michael Lock; Paul M Harari; Wolfgang A Tomé; Jack Fowler; Thomas Rockwell Mackie; Mark Ritter; Jeff Kapatoes; Lisa Forrest; Richard Chappell; Bhudatt Paliwal; Minesh P Mehta Journal: Technol Cancer Res Treat Date: 2006-10
Authors: Hendrik P Bijl; Peter van Luijk; Rob P Coppes; Jacobus M Schippers; Antonius W T Konings; Albert J van der Kogel Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-15 Impact factor: 7.038
Authors: Hendrik P Bijl; Peter van Luijk; Rob P Coppes; Jacobus M Schippers; Antonius W T Konings; Albert J van der Kogel Journal: Int J Radiat Oncol Biol Phys Date: 2003-09-01 Impact factor: 7.038
Authors: Severin Kampfer; Stefan Schell; Marciana N Duma; Jan J Wilkens; Peter Kneschaurek Journal: J Appl Clin Med Phys Date: 2011-11-15 Impact factor: 2.102
Authors: Dirk Rades; Jasmin N Evers; Amira Bajrovic; Theo Veninga; Johann H Karstens; Steven E Schild Journal: Strahlenther Onkol Date: 2014-03-22 Impact factor: 3.621
Authors: David J Noble; Ping-Lin Yeap; Shannon Y K Seah; Karl Harrison; Leila E A Shelley; Marina Romanchikova; Amy M Bates; Yaolin Zheng; Gillian C Barnett; Richard J Benson; Sarah J Jefferies; Simon J Thomas; Raj Jena; Neil G Burnet Journal: Radiother Oncol Date: 2018-07-23 Impact factor: 6.280